MammaPrint BluePrint illuminating tumor biology

A FULL picture of your patient’s tumor to optimize treatment planning.

Full Picture of your patient's tumor to optimize treatment planning

MammaPrint® + BluePrint® inform multiple treatment decisions*, beyond chemotherapy, in HR+HER2-negative early breast cancer.

Pathological response

Dive deeper into the data with our Medical team

Request Data Review / Additional Data:
* indicates required
Select the data you would like to learn more about